Your browser doesn't support javascript.
loading
Role of ablation therapy in conjunction with surgical resection for neuroendocrine tumors involving the liver.
Ostapenko, Alexander; Stroever, Stephanie; Eyasu, Lud; Kim, Minha; Aploks, Krist; Dong, Xiang Da; Seshadri, Ramanathan.
Afiliação
  • Ostapenko A; Department of General Surgery, Danbury Hospital, Danbury, CT 06810, United States. sashaostapenko27@gmail.com.
  • Stroever S; Department of Research and Innovation, Nuvance Health, Danbury, CT 06810, United States.
  • Eyasu L; Department of General Surgery, Danbury Hospital, Danbury, CT 06810, United States.
  • Kim M; Department of General Surgery, Danbury Hospital, Danbury, CT 06810, United States.
  • Aploks K; Department of General Surgery, Danbury Hospital, Danbury, CT 06810, United States.
  • Dong XD; Division of Surgical Oncology/Hepato-Pancreato-Biliary Surgery, Danbury Hospital, Danbury, CT 06810, United States.
  • Seshadri R; Division of Surgical Oncology/Hepato-Pancreato-Biliary Surgery, Danbury Hospital, Danbury, CT 06810, United States.
World J Gastrointest Surg ; 16(3): 768-776, 2024 Mar 27.
Article em En | MEDLINE | ID: mdl-38577070
ABSTRACT

BACKGROUND:

Resection of hepatic metastasis from neuroendocrine tumors (NETs) improves quality of life and prolongs 5-year survival. Ablation can be utilized with surgery to achieve complete resection. Although several studies report long-term outcomes for patients undergoing ablation, none have explored perioperative effects of ablation in patients with metastatic NETs.

AIM:

To determine if intra-operative ablation during hepatectomy increases risk of adverse outcomes such as surgical site infections (SSIs), bleeding, and bile leak.

METHODS:

A retrospective analysis of the hepatectomy National Surgical Quality Improvement Program database from 2015-2019 was performed to determine the odds of SSIs, bile leaks, or bleeding in patients undergoing intraoperative ablation when compared to hepatectomy alone.

RESULTS:

Of the 966 patients included in the study, 298 (30.9%) underwent ablation during hepatectomy. There were 78 (11.7%) patients with SSIs in the hepatectomy alone group and 39 (13.1%) patients with a SSIs in the hepatectomy with ablation group. Bile leak occurred in 41 (6.2%) and 14 (4.8%) patients in the two groups, respectively; bleeding occurred in 117 (17.5%) and 33 (11.1%), respectively. After controlling for confounding variables, ablation did not increase risk of SSI (P = 0.63), bile leak (P = 0.34) or bleeding (P = 0.07) when compared to patients undergoing resection alone on multivariate analysis.

CONCLUSION:

Intraoperative ablation with hepatic resection for NETs is safe in the perioperative period without significant increased risk of infection, bleeding, or bile leak. Surgeons should utilize this modality when appropriate to achieve optimal disease control and outcomes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article